Don't be caught off-guard: NantHealth NH releases its next round of earnings Wednesday.
Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for Wednesday's Q4 earnings announcement after the bell.
Earnings and Revenue
Sell-side analysts are expecting NantHealth's loss per share to be near 14 cents on sales of $23.28 million.
NantHealth reported a per-share loss of 18 cents when it published results during the same quarter last year. Sales in that period totaled $24 million. Sales would be down 3.33 percent from the same quarter last year.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
EPS Estimate | -0.13 | -0.15 | -0.17 | |
EPS Actual | -0.13 | -0.18 | -0.24 | -0.18 |
Stock Performance
Over the past 52-week period, shares of NantHealth have declined 11.46 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on NantHealth stock is a Buy. The strength of this rating has risen over the past 90 days.
Conference Call
The NantHealth's Q4 conference call is scheduled to begin at 4:30 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.